Gastroenterology Clinical Trials List


A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate the Clinical Efficacy and Safety of Induction Therapy with RPC1063 in Patients with Moderately to Severely Active Ulcerative Colitis

Type of Disease:

Ulcerative colitis, moderate to severe

Locations Available:

NYU Langone Medical Center
Long Island Clinical Research Associates
1000 Northern Boulevard, Suite 160
Great Neck NY 11021

Principal Investigator:

Seymour Katz, MD


Anthony Vacchio


Return to the Gastroenterology Clinical Trials List.